Ofer Hi-Tech is the famous Corporate Investor, which was founded in 1997. The company was established in Asia in Israel. The leading representative office of defined Corporate Investor is situated in the Tel Aviv.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Ofer Hi-Tech, startups are often financed by Yozma Group, Viola Partners, VantagePoint Capital Partners. The meaningful sponsors for the fund in investment in the same round are Yozma Group, Viola Partners, VantagePoint Capital Partners. In the next rounds fund is usually obtained by XT Investments, Yozma Group, Viola Partners.
Among the most popular portfolio startups of the fund, we may highlight Better Place, YaData, Kailight Photonics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biotechnology. The fund has exact preference in some founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little.
The higher amount of exits for fund were in 2015. This Ofer Hi-Tech works on 9 percentage points more the average amount of lead investments comparing to the other organizations. Considering the real fund results, this Corporate Investor is 1 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2007. The average startup value when the investment from Ofer Hi-Tech is more than 1 billion dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
Related Funds
Funds with similar focus
Fund Name | Location |
Altimeter Capital | California, Menlo Park, United States |
Ascendant BioCapital | Delaware, United States, Wilmington |
Collider Ventures | Israel, Tel Aviv, Tel Aviv District |
Debioinvestment | - |
Demium Startups | Comunidad Valenciana, Spain, Valencia |
Dundee Corporation | Canada, Ontario, Toronto |
Esker | France, Lyon, Rhone-Alpes |
Global Asset Capital | California, Palo Alto, United States |
Huimi Investment Management | China, Fujian, Xiamen |
INES | Japan, Tokyo |
INNOTECH FRONTIER | Burlingame, California, United States |
National Cancer Research Institute | England, London, United Kingdom |
Navare Invest | - |
OMX Ventures | Boston, Massachusetts, United States |
Shawmut Capital Partners | Boston, Massachusetts, United States |
Strategic Innovation Fund (SIF) | Canada, Kentucky, United States |
Stroud Companies | Dallas, Texas, United States |
Techstars Hub71 | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates |
The Conscious Fund | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
$200M | 11 Nov 2011 | Palo Alto, California, United States | |||
Checkmarx | 10 Oct 2011 | Tel Aviv District | |||
$350M | 25 Jan 2010 | Palo Alto, California, United States | |||
ActiViews | $5M | 22 Jan 2010 | North District | ||
AngioSlide | $8M | 01 Aug 2009 | Colorado, United States | ||
YouLicense | $1M | 01 Apr 2009 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Enzymotec | $11M | 02 Feb 2009 | Israel, North District | ||
AngioSlide | $8M | 01 May 2008 | Colorado, United States | ||
ActiViews | $5M | 13 Nov 2007 | Israel, North District, Israel |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
$200M | 11 Nov 2011 | Palo Alto, California, United States | |||
Checkmarx | 10 Oct 2011 | Tel Aviv District | |||
$350M | 25 Jan 2010 | Palo Alto, California, United States | |||
ActiViews | $5M | 22 Jan 2010 | North District | ||
AngioSlide | $8M | 01 Aug 2009 | Colorado, United States | ||
YouLicense | $1M | 01 Apr 2009 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Enzymotec | $11M | 02 Feb 2009 | Israel, North District | ||
AngioSlide | $8M | 01 May 2008 | Colorado, United States | ||
ActiViews | $5M | 13 Nov 2007 | Israel, North District, Israel |